No Data
No Data
No Data
No Data
No Data
BioSyent Announces Extension of RepaGyn and Proktis-M Agreement
Yahoo FinanceApr 15 16:31 ET
BioSyent Inc. Spotlights at Investor Conference
TipRanksApr 10 09:08 ET
BioSyent to Present at LD Micro New York Investor Conference
Yahoo FinanceApr 1 14:00 ET
BioSyent Announces Grant of Restricted Share Units
Yahoo FinanceMar 27 18:34 ET
Earnings Call: BioSyent Inc. Reports Robust Growth in Q4 and FY 2023
InvestingMar 14 21:20 ET
Earnings Call Summary | BIOSYENT INC(BIOYF.US) Q4 2023 Earnings Conference
The following is a summary of the BioSyent Inc. (BIOYF) Q4 2023 Earnings Call Transcript:Financial Performance:BioSyent reports Q4 sales around $8.3 million, marking an 11% increase from the previous
moomoo AIMar 14 15:04 ET · Conference Call
No Data
No Data